Mediators of Inflammation

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine

A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management

Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts

Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis

Faster onset of action with topical levocabastine than with oral cetirizine

Introduction

Calendar

Book review

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility

Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNFα

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime

Nitric oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats

Lower leukotriene C₄ levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy

Mediators of Inflammation

Table of Contents

Table of Contents: 1995

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine

A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management

Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts

Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis

Faster onset of action with topical levocabastine than with oral cetirizine

Introduction

Calendar

Book review

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility

Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNFα

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime

Nitric oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats

Lower leukotriene C₄ levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy

Mediators of Inflammation

Table of Contents

Table of Contents: 1995

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine

A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management

Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts

Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis

Faster onset of action with topical levocabastine than with oral cetirizine

Introduction

Calendar

Book review

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility

Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNFα

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime

Nitric oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats

Lower leukotriene C4 levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy

Lower leukotriene C₄ levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy